Home » Community Blog » Extended-Release Opioid Agonist Products: A Community Position Statement

Extended-Release Opioid Agonist Products: A Community Position Statement

4 December, 2019

In recent years, services and options for people with opiate dependence have expanded to include a range of prolonged-release buprenorphine formulations. Although these new options can represent the right solution for some individuals, a significant risk of a coercive use exists, especially in countries where people who use drugs are highly criminalised and discriminated against. In such contexts, these medications could be used as a means to reduce people’s choice with regard to their bodily integrity and their drug use. In return, this could essentially enforce prohibition and morally-driven ideas of abstinence.

This paper outlines the position of the International Network of People who Use Drugs (INPUD), developed after extensive research and in consultation with people who use drugs and our allies. It was written in collaboration with, and endorsed by, the International Network of Women who Use Drugs (INWUD), the Asian Network of People who Use Drugs (ANPUD), the African Network of People who Use Drugs (AfricaNPUD), the Urban Survivors Union (USU), the Eurasian Network of People who Use Drugs (ENPUD), and the Latin American Network of People who Use Drugs (LANPUD).